Carmen Herling

2.1k total citations
23 papers, 320 citations indexed

About

Carmen Herling is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Carmen Herling has authored 23 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 11 papers in Pathology and Forensic Medicine and 11 papers in Immunology. Recurrent topics in Carmen Herling's work include Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immunodeficiency and Autoimmune Disorders (9 papers). Carmen Herling is often cited by papers focused on Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immunodeficiency and Autoimmune Disorders (9 papers). Carmen Herling collaborates with scholars based in Germany, United States and Denmark. Carmen Herling's co-authors include Michael Hallek, Jasmin Bahlo, Marco Herling, Giuliano Crispatzu, Stephan Stilgenbauer, Kirsten Fischer, Carsten Utoft Niemann, Jens Lundgren, Rudi Agius and Christian Brieghel and has published in prestigious journals such as Nature Communications, Blood and Bioinformatics.

In The Last Decade

Carmen Herling

21 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmen Herling Germany 9 182 127 108 74 59 23 320
P. Musto United States 7 98 0.5× 115 0.9× 35 0.3× 48 0.6× 47 0.8× 18 227
Cassandra M Kerr United States 12 186 1.0× 59 0.5× 91 0.8× 180 2.4× 39 0.7× 42 480
Timothy L. Chen United States 8 109 0.6× 46 0.4× 39 0.4× 333 4.5× 159 2.7× 10 449
Steffen Falgreen Denmark 10 33 0.2× 94 0.7× 60 0.6× 135 1.8× 67 1.1× 19 255
Dayang Hui China 8 66 0.4× 39 0.3× 47 0.4× 51 0.7× 116 2.0× 13 285
Vera Ademà United States 12 263 1.4× 97 0.8× 62 0.6× 278 3.8× 66 1.1× 56 639
Elizabeth Carideo United States 5 53 0.3× 138 1.1× 123 1.1× 150 2.0× 130 2.2× 5 339
P. Liu United States 5 23 0.1× 91 0.7× 55 0.5× 144 1.9× 45 0.8× 11 410
Luke B. Fletcher United States 8 71 0.4× 42 0.3× 61 0.6× 168 2.3× 64 1.1× 16 328
Eugene Kim United States 10 32 0.2× 57 0.4× 69 0.6× 127 1.7× 160 2.7× 24 378

Countries citing papers authored by Carmen Herling

Since Specialization
Citations

This map shows the geographic impact of Carmen Herling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Herling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Herling more than expected).

Fields of papers citing papers by Carmen Herling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Herling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Herling. The network helps show where Carmen Herling may publish in the future.

Co-authorship network of co-authors of Carmen Herling

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Herling. A scholar is included among the top collaborators of Carmen Herling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Herling. Carmen Herling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Pacholewska, Alicja, Matthias Lienhard, Kerstin Becker, et al.. (2024). Long-read transcriptome sequencing of CLL and MDS patients uncovers molecular effects of SF3B1 mutations. Genome Research. 34(11). 1832–1848. 8 indexed citations
4.
Vučinić, Vladan, Luise Fischer, Enrica Bach, et al.. (2023). Apheresis for Production of Chimeric Antigen Receptor (CAR) T Cells in Patients with Multiple Myeloma - Clinical Factors, Cell Composition and T Cell Senescence. Blood. 142(Supplement 1). 3521–3521. 1 indexed citations
5.
Brieghel, Christian, Rudi Agius, Caspar da Cunha‐Bang, et al.. (2022). Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?. European Journal Of Haematology. 108(5). 369–378. 12 indexed citations
6.
Grimm, Christina, Carmen Herling, Michelle Hussong, et al.. (2022). Evaluation of a Prognostic Epigenetic Classification System in Chronic Lymphocytic Leukemia Patients. Biomarker Insights. 17. 3399334468–3399334468. 3 indexed citations
7.
Pacholewska, Alicja, Christina Grimm, Carmen Herling, et al.. (2021). Altered DNA Methylation Profiles in SF3B1 Mutated CLL Patients. International Journal of Molecular Sciences. 22(17). 9337–9337. 4 indexed citations
8.
Gödel, Philipp, Jan‐Michel Heger, Nadine Kutsch, et al.. (2021). Hematologic Rescue of CAR T-cell–mediated Prolonged Pancytopenia Using Autologous Peripheral Blood Hematopoietic Stem Cells in a Lymphoma Patient. HemaSphere. 5(3). e545–e545. 15 indexed citations
9.
Agius, Rudi, Christian Brieghel, Michael Asger Andersen, et al.. (2020). Machine learning can identify newly diagnosed patients with CLL at high risk of infection. Nature Communications. 11(1). 363–363. 81 indexed citations
10.
Herling, Carmen, Kevin R. Coombes, Axel Benner, et al.. (2019). Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study. The Lancet Oncology. 20(11). 1576–1586. 15 indexed citations
11.
Abruzzo, Lynne V., Carmen Herling, George A. Călin, et al.. (2018). Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways. Haematologica. 103(12). 2069–2078. 21 indexed citations
12.
Al‐Sawaf, Othman, Jasmin Bahlo, Sandra Robrecht, et al.. (2018). Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia. British Journal of Haematology. 183(5). 727–735. 7 indexed citations
13.
Crispatzu, Giuliano, Mohammad R. Toliat, Peter Nürnberg, et al.. (2017). Semi-automated cancer genome analysis using high-performance computing. Human Mutation. 38(10). 1325–1335. 6 indexed citations
14.
Crispatzu, Giuliano, Elena Vasyutina, Stefan Zittrich, et al.. (2016). A Novel Recombinant Anti-CD22 Immunokinase Delivers Proapoptotic Activity of Death-Associated Protein Kinase (DAPK) and Mediates Cytotoxicity in Neoplastic B Cells. Molecular Cancer Therapeutics. 15(5). 971–984. 8 indexed citations
15.
Al‐Sawaf, Othman, Kirsten Fischer, Carmen Herling, et al.. (2016). Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial. European Journal Of Haematology. 98(3). 254–262. 10 indexed citations
16.
Langerbeins, Petra, et al.. (2016). Risk-Adapted Therapy in Early-Stage Chronic Lymphocytic Leukemia. Oncology Research and Treatment. 39(1-2). 18–24. 7 indexed citations
17.
Crispatzu, Giuliano, Alexandra Schrader, Michael Nothnagel, Marco Herling, & Carmen Herling. (2016). A Critical Evaluation of Analytic Aspects of Gene Expression Profiling in Lymphoid Leukemias with Broad Applications to Cancer Genomics. AIMS Medical Science. 3(3). 248–271.
18.
Herling, Carmen, Janine Altmüller, Hölger Thiele, et al.. (2016). Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy. Blood. 128(3). 395–404. 71 indexed citations
19.
Prinz, Christian, Elena Vasyutina, Alexandra Schrader, et al.. (2015). Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden. Molecular Cancer. 14(1). 114–114. 21 indexed citations
20.
Vollbrecht, Claudia, Fabian Mairinger, Martin Peifer, et al.. (2015). Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing. PLoS ONE. 10(6). e0129544–e0129544. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Musto Breakdown of academic impact, for papers by Cassandra M Kerr Breakdown of academic impact, for papers by Timothy L. Chen Breakdown of academic impact, for papers by Steffen Falgreen Breakdown of academic impact, for papers by Dayang Hui Breakdown of academic impact, for papers by Vera Ademà Breakdown of academic impact, for papers by Elizabeth Carideo Breakdown of academic impact, for papers by P. Liu Breakdown of academic impact, for papers by Luke B. Fletcher Breakdown of academic impact, for papers by Eugene Kim
Rankless by CCL
2026